Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AGL
Deeply overvalued
agilon health, inc.
Price$82.39
Model IV$41.18
P/IV1.96
Premium +100%
Return to IV: -50.0%
Market implies +15.5%/yr
vs model +40.5% · below model
BRTX
Deeply overvalued
BioRestorative Therapies, Inc.
Price$1.91
Model IV$1.00
P/IV1.91
Premium +91%
Return to IV: -47.8%
Market implies +8.2%/yr
vs model +50.0% · below model
CCEL
Deeply undervalued
CRYO CELL INTERNATIONAL INC
Price$4.36
Model IV$6.88
P/IV0.61
Discount 37%
Return to IV: +57.7%
Market implies -4.5%/yr
vs model +7.7% · below model
DVA
Deeply undervalued
DAVITA INC.
Price$179.25
Model IV$590.72
P/IV0.33
Discount 70%
Return to IV: +229.6%
Market implies -6.8%/yr
vs model +9.9% · below model
FMS
Deeply undervalued
Fresenius Medical Care AG
Price$21.06
Model IV$106.03
P/IV0.20
Discount 80%
Return to IV: +403.5%
Market implies -15.8%/yr
vs model +6.5% · below model
MCTA
Valuation N/A
Charming Medical Ltd
Price$29.36
Model IV—
P/IV—
Market implies +65.9%/yr
MGRX
Deeply overvalued
MANGOCEUTICALS, INC.
Price$0.42
Model IV$0.13
P/IV3.37
Premium +231%
Return to IV: -69.8%
Market implies +18.0%/yr
vs model +50.0% · below model
NIVF
Valuation N/A
NewGenIvf Group Ltd
Price$0.07
Model IV—
P/IV—
Limited data — see page
NIVFW
Valuation N/A
NewGenIvf Group Ltd
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
PARK
Valuation N/A
Park Dental Partners, Inc.
Price$20.25
Model IV—
P/IV—
Limited data — see page
PGNY
Deeply overvalued
Progyny, Inc.
Price$27.93
Model IV$18.77
P/IV1.38
Premium +49%
Return to IV: -32.8%
Market implies +15.9%/yr
vs model +15.0% · in line
SHC
Deeply overvalued
Sotera Health Co
Price$18.06
Model IV$6.60
P/IV2.37
Premium +174%
Return to IV: -63.5%
Market implies +19.7%/yr
vs model +7.0% · above model
VMD
Deeply undervalued
VIEMED HEALTHCARE, INC.
Price$9.52
Model IV$29.09
P/IV0.34
Discount 67%
Return to IV: +205.6%
Market implies -22.4%/yr
vs model +23.3% · below model